Pancreatic Cancer Research

ResearcherSir Run Run Shaw HospitalNo recent work listed

Zhengrong Wu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0003-9531-2751; OpenAlex author ID A5106418199. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2017: 2 papers · 2018: none · 2019: 2 papers

Papers 4

  1. IFN-γ down-regulates the PD-1 expression and assist nivolumab in PD-1-blockade effect on CD8+ T-lymphocytes in pancreatic cancer. Co-author DOI 10.1186/s12885-019-6145-8↗
  2. Expression of DEK in pancreatic cancer and its correlation with clinicopathological features and prognosis. Last author DOI 10.7150/jca.27405↗
  3. A novel scoring system to analyze combined effect of lifestyle factors on pancreatic cancer risk: a retrospective case-control study. Co-author DOI 10.1038/s41598-017-13182-w↗
  4. Overexpressions of miR-212 are associated with poor prognosis of patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.3233/cbm-160671↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Guoping Ding · 4 shared papers, 2017–2019 · strength 0.41
  2. Liping Cao · 3 shared papers, 2017–2019 · strength 0.31
  3. Mingjie Zhang · 1 shared paper, 2019 · strength 0.11
  4. Tao Shen · 1 shared paper, 2019 · strength 0.11
  5. Ting Zhao · 1 shared paper, 2019 · strength 0.11
  6. Liangjing Zhou · 1 shared paper, 2017 · strength 0.10
  7. Liping Cao · 1 shared paper, 2017 · strength 0.10
  8. Guixing Jiang · 1 shared paper, 2017 · strength 0.08
  9. Tianshu Pang · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.